查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1985490

呼吸系統診斷市場：2026-2032年全球市場預測（按診斷測試、患者群體、提供的服務和最終用戶分類）

Respiratory Diagnostics Market by Diagnostic Tests, Patient Demographics, Offerings, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，呼吸系統診斷市場價值將達到 72.6 億美元，到 2026 年將成長至 78.6 億美元，到 2032 年將達到 131.6 億美元，複合年成長率為 8.86%。

主要市場統計數據
基準年 2025 72.6億美元
預計年份：2026年 78.6億美元
預測年份 2032 131.6億美元
複合年成長率 (%) 8.86%

在新興技術和監管趨勢的驅動下，應對複雜的呼吸系統診斷環境。

呼吸系統診斷領域正經歷前所未有的快速變革，這既得益於技術創新，也得益於全​​球健康問題的迫切性。慢性呼吸系統疾病盛行率的上升和患者健康意識的增強，正推動該行業進入一個充滿活力的演進階段。先進的分析工具、照護現場設備和數位健康平台的融合，正在建立更精準、更快捷、更容易取得的診斷路徑。此外，關鍵市場不斷變化的監管要求也帶來了新的合規挑戰，要求整個價值鏈採取適應性策略。

探索關鍵的技術和營運變革，以重塑後疫情時代的呼吸系統診斷生態系統。

過去幾年，呼吸系統診斷領域因數位醫療的突破性進展和人工智慧的融合而發生了翻天覆地的變化。機器學習演算法如今能夠支援高解析度影像的分析，使臨床醫生能夠更精準地檢測早期異常。同時，基於雲端的分析平台實現了跨多個管道患者數據的無縫整合，從而提供更全面的疾病進展洞察。這些變革不僅縮短了診斷時間，也降低了整體營運成本。

分析 2025 年美國關稅對供應鏈、成本結構和市場適應的綜合影響。

美國2025年實施的關稅調整對全球呼吸系統診斷供應鏈產生了重大影響。進口零件的關稅上調，迫使設備製造商重新評估其籌資策略和合作夥伴網路。結果，生產成本大幅上升，尤其是高精度成像系統和先進分子檢測套組的生產成本。為因應這項挑戰，一些主要企業採取了近岸外包策略，將組裝遷至更靠近終端市場的位置，以減輕關稅的影響並確保供應的連續性。

從測試方法、人口統計群體、解決方案和最終用戶應用等不同角度分析市場觀點。

對診斷檢測技術的詳細分析表明，動脈血氣分析和血液常規檢查等血液檢測仍然是評估呼吸功能和識別全身性發炎的基本工具。包括胸部X光片、 電腦斷層掃描和MRI掃描在內的影像學平台仍然是可視化結構異常的關鍵方法。同時，肺功能檢查，例如肺活量測定、彌散能力測量和肺容量評估，對於追蹤疾病進展和指導治療性介入至關重要。 PCR檢測、抗原檢測和生物標記分析等先進的分子檢測進一步提高了診斷準確性，而脈搏血氧計和痰液分析通訊協定則可在臨床和家庭環境中進行持續監測。

分析美洲、歐洲、中東和非洲以及亞太地區呼吸診斷市場的區域成長要素和市場細微差別。

呼吸系統診斷領域的區域發展趨勢因醫療基礎設施成熟度、法規環境和經濟因素的不同而呈現出明顯的差異。在美洲，先進的臨床網路和完善的保險報銷體系推動了高階影像系統和分子診斷技術的快速普及。同時，研究經費和公共衛生舉措也進一步增強了市場發展動能。歐洲、中東和非洲地區的市場環境則更為複雜：西歐市場強調技術進步和嚴格的監管合規，而中東和非洲國家則致力於透過官民合作關係和有針對性的疾病篩檢計畫來提升自身能力。

揭示引領呼吸系統診斷技術發展的主要企業所採用的競爭和創新策略。

呼吸系統診斷領域的主要企業正著力於幾項關鍵策略，以保持其競爭優勢。成像系統製造商與軟體分析供應商之間正在建立策略合作夥伴關係，將硬體創新與先進的數據分析演算法相結合。這種合作模式正在加速整合診斷平台的部署，從而實現無縫資料交換和遠端存取。同時，大型診斷集團收購專注於特定領域的分子檢測開發公司，正在增強其檢測產品組合，擴大疾病檢測範圍，並促進個人化治療方案的發展。

呼吸系統診斷產業在加強創新、協作和業務永續營運方面面臨的富有洞察力的策略挑戰。

為了最大限度地掌握市場機遇，產業領導企業應優先投資於可互通的數位平台，這些平台能夠整合各種診斷資料流並實現即時決策支援。透過與軟體開發商和學術機構建立協作生態系統，各組織可以共同開發先進的分析解決方案，以預測不斷變化的臨床需求。同時，透過雙重採購和近岸外包實現供應鏈多元化，可以減輕關稅相關的干擾，並確保設備供應穩定。

闡明一個嚴格的多階段研究框架，該框架整合了主要檢驗和次要分析，以實現可靠的呼吸系統診斷智慧。

本研究採用嚴謹的多階段方法，確保最高的準確性和可靠性。主要資料收集包括對關鍵意見領袖（KOL）的全面訪談，這些意見領袖包括呼吸科醫生、實驗室管理人員和監管專家，旨在獲取有關新興趨勢、臨床工作流程和採購因素的第一手資料。除這些定性見解外，本研究還對公開文件、技術白皮書和監管資料庫進行了詳細的審查，為二手資料的收集奠定了堅實的基礎。

整合關鍵發現和未來展望，以指導呼吸系統診斷領域的策略發展和產業前景。

綜合本摘要中的關鍵見解，我們可以發現呼吸系統診斷領域正步入一個以數位整合、策略性供應鏈重組和協同創新為特徵的新時代。先進影像平台與分子檢測技術的融合，正推動我們對呼吸系統疾病有更深入的理解。同時，監理改革和關稅政策也凸顯了營運彈性和積極主動的相關人員參與的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 呼吸系統診斷市場（依診斷測試分類）

  • 驗血
    • 動脈血氣分析
    • 血液常規檢查
  • 影像檢查
    • 胸部X光片
    • 電腦斷層掃描
    • 核磁共振掃描
  • 肺功能測試
    • 擴散能力測試
    • 肺容量測試
    • 肺功能測定
  • 分子檢測
    • 抗原檢測
    • 生物標記檢測
    • PCR檢測
  • 脈搏血氧計
  • 痰液檢查

第9章 按患者細分分類的呼吸系統診斷市場

  • 成人版
  • 老年人
  • 兒童

第10章 呼吸系統診斷市場：依產品/服務分類

  • 裝置
    • 體容積測量裝置
    • 醫學影像系統
    • 氣體分析儀
    • 肺活量測定系統
  • 服務
  • 軟體
    • 數據分析軟體
    • 影像分析軟體
    • 肺功能測試（PFT）軟體

第11章 呼吸系統診斷市場：依最終用戶分類

  • 學術機構
  • 診斷檢查室
  • 醫院和診所
  • 研究機構

第12章 呼吸系統診斷市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 呼吸系統診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 呼吸系統診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國呼吸系統診斷市場

第16章：中國呼吸系統診斷市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Adaltis Srl
  • Altona Diagnostics GmbH
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bioneer Corporation
  • CerTest Biotec SL
  • Daan Gene Co., Ltd.
  • Diatech Pharmacogenetics srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • Merck KGaA
  • ProAxsis by NetScientific PLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • ResMed Corp.
  • Sansure Biotech Inc.
  • SDI Diagnostics, Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Vitalograph Ltd.
  • ZeptoMetrix LLC
Product Code: MRR-894699F5EBCB

The Respiratory Diagnostics Market was valued at USD 7.26 billion in 2025 and is projected to grow to USD 7.86 billion in 2026, with a CAGR of 8.86%, reaching USD 13.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.26 billion
Estimated Year [2026] USD 7.86 billion
Forecast Year [2032] USD 13.16 billion
CAGR (%) 8.86%

Navigating the Complex Respiratory Diagnostics Environment with Emerging Technologies and Regulatory Dynamics Steering Future Developments

The respiratory diagnostics landscape has experienced an unprecedented surge in both technological innovation and global health urgency. Driven by rising prevalence of chronic respiratory conditions and heightened patient awareness, the industry has entered a phase of dynamic evolution. Advanced analytical tools, point-of-care devices, and digital health platforms are converging to create more precise, rapid, and accessible diagnostic pathways. Moreover, shifting regulatory requirements across major markets have introduced new compliance challenges, necessitating adaptive strategies across the entire value chain.

Amid these complexities, this report provides a comprehensive exploration of the key market forces influencing respiratory diagnostics. It paints a clear picture of how technological breakthroughs are intersecting with demographic trends, healthcare protocols, and reimbursement frameworks. By establishing a foundational understanding of current drivers and barriers, this introduction sets the stage for deeper analysis. As you navigate this landscape, the insights presented here will illuminate strategic opportunities and potential pitfalls, empowering decision-makers to chart a forward-looking course in an increasingly competitive environment.

Exploring Pivotal Technological and Operational Transformations Reshaping the Respiratory Diagnostics Ecosystem in a Post-Pandemic Era

Over the past several years, respiratory diagnostics has been transformed by breakthroughs in digital health and the integration of artificial intelligence. Machine learning algorithms now support high-resolution imaging interpretation, enabling clinicians to detect early-stage anomalies with greater accuracy. Meanwhile, cloud-based analytics platforms facilitate the seamless aggregation of patient data across multiple touchpoints, offering more holistic insights into disease progression. These shifts have not only accelerated diagnostic timelines but also lowered overall operational costs.

In addition to technological advances, the industry is experiencing a paradigm shift toward decentralized care models. Point-of-care testing solutions are proliferating beyond hospital settings into community clinics and home-based environments. This expansion is accompanied by growing emphasis on patient empowerment and remote monitoring, which together foster proactive disease management. Consequently, manufacturers and service providers are increasingly focusing on modular, portable solutions that can adapt to a range of clinical workflows. These transformative forces are redefining traditional value chains, encouraging stakeholders to adopt agile development and collaborative partnerships.

Analyzing the Compound Effects of United States Tariff Implementations in 2025 on Supply Chains, Cost Structures, and Market Adaptations

The United States' tariff adjustments implemented in 2025 have exerted a considerable influence on the global respiratory diagnostics supply chain. Imported components faced elevated duties, prompting device manufacturers to reassess sourcing strategies and partner networks. As a result, production costs experienced a noticeable escalation, particularly for high-precision imaging systems and advanced molecular assay kits. In response, several key players pursued nearshoring initiatives, relocating assembly lines closer to end markets to mitigate duty impacts and ensure delivery continuity.

Beyond immediate cost implications, these tariff measures have catalyzed broader strategic realignments. Organizations have intensified supplier diversification efforts to reduce dependency on any single geographic region. Concurrently, there has been a surge in investment toward local manufacturing capabilities and quality control infrastructure. These adjustments have not only buffered the effects of trade policy volatility but also fostered resilience in the face of future disruptions. Overall, the cumulative impact of the 2025 tariff regime underscores the critical importance of supply chain agility and strategic foresight in managing regulatory headwinds.

Unpacking Diverse Market Segmentation Perspectives Highlighting Test Modalities, Demographic Cohorts, Solution Offerings, and End-User Applications

An in-depth look at diagnostic test modalities reveals that blood-based assessments such as arterial blood gas analysis and complete blood count remain foundational tools for evaluating respiratory function and identifying systemic inflammation. Imaging platforms spanning chest X-rays, CT scans, and MRI scans continue to serve as critical modalities for visualizing structural abnormalities. At the same time, lung function tests like spirometry, diffusion capacity measurements, and lung volume assessments are essential for tracking disease progression and guiding therapeutic interventions. Advanced molecular tests including PCR assays, antigen detection, and biomarker profiling further enrich diagnostic accuracy, while pulse oximetry and sputum analysis protocols facilitate ongoing monitoring in both clinical and at-home settings.

Patient demographic segmentation highlights how adult populations drive baseline demand, while geriatric cohorts increasingly rely on complex diagnostic combinations to manage age-related pulmonary disorders. Pediatric segments, by contrast, often prioritize minimally invasive and radiation-free techniques, aligning with safety considerations. Examining market offerings underscores that equipment portfolios-ranging from spirometry systems and gas analyzers to body plethysmographs and diagnostic imaging units-form the backbone of capital investment. Complementary services such as calibration, maintenance, and clinical support services reinforce equipment performance. Meanwhile, specialized software solutions offering data analytics, imaging processing, and pulmonary function testing management are gaining traction as indispensable components of integrated diagnostic ecosystems. Finally, end-user analysis indicates that hospitals and clinics represent the primary consumption hubs, followed by diagnostic laboratories, research institutes, and academic institutions, each driving tailored requirements for throughput, data integration, and reporting capabilities.

Dissecting Regional Growth Drivers and Market Nuances across the Americas, Europe Middle East Africa, and Asia-Pacific Respiratory Diagnostics Arenas

Regional dynamics in respiratory diagnostics exhibit clear differentiation driven by healthcare infrastructure maturity, regulatory environments, and economic factors. In the Americas, advanced clinical networks and expansive reimbursement regimes catalyze rapid adoption of high-end imaging systems and molecular diagnostics. Meanwhile, research funding and public health initiatives further strengthen market momentum. The Europe, Middle East, and Africa region presents a multifaceted environment where Western European markets emphasize technological sophistication and stringent regulatory compliance, while Middle Eastern and African nations pursue capacity building through public-private partnerships and targeted disease screening programs.

Asia-Pacific stands out for its diverse market trajectories, as developed economies such as Japan and Australia leverage digital health integration, whereas emerging markets prioritize cost-effective, portable testing solutions to broaden diagnostic reach. Government-led health campaigns and expanding private sector participation are key drivers of growth across the region. Collectively, these regional nuances underscore the importance of tailored go-to-market strategies that align with local regulatory frameworks, reimbursement landscapes, and healthcare delivery models.

Illuminating Competitive Dynamics and Innovation Strategies Employed by Leading Enterprises Shaping the Respiratory Diagnostics Sector's Evolution

Leading organizations within the respiratory diagnostics sphere have converged on a few critical strategies to maintain competitive advantage. Strategic partnerships between imaging system manufacturers and software analytics providers have emerged, combining hardware innovations with advanced data interpretation algorithms. This collaborative approach has accelerated the roll-out of integrated diagnostic platforms capable of seamless data exchange and remote accessibility. Simultaneously, acquisitions of niche molecular assay developers by large diagnostic conglomerates have bolstered assay portfolios, enhancing the scope of disease detection and personalized treatment planning.

New entrants differentiate through agile business models, offering subscription-based or as-a-service equipment deployment to reduce capital expenditure burdens on healthcare providers. Additionally, several companies have established centers of excellence in emerging markets to support localized R&D and regulatory approvals. The focus on continuous product lifecycle management, guided by post-market surveillance and real-world evidence collection, further demonstrates how top-tier players are leveraging data-driven feedback loops to refine their offerings. These collective competitive maneuvers illustrate a sector characterized by rapid consolidation, innovation-driven partnerships, and evolving commercial frameworks.

Delivering Insightful Strategic Imperatives to Enhance Innovation, Collaboration, and Operational Resilience within the Respiratory Diagnostics Industry

To capitalize on market opportunities, industry leaders should prioritize investment in interoperable digital platforms that integrate diverse diagnostic data streams, enabling real-time decision support. By fostering collaborative ecosystems with software developers and academic institutions, organizations can co-create advanced analytics solutions that anticipate evolving clinical needs. Concurrently, diversifying supply chains through dual sourcing and nearshoring can mitigate tariff-related disruptions and ensure consistent device availability.

Moreover, pursuing modular product designs will allow rapid customization for distinct end-user environments, from high-throughput hospital labs to decentralized community clinics. Engaging proactively with regulatory authorities and participating in standards-development consortia will streamline approval pathways and set benchmarks for quality and safety. Finally, embedding sustainability principles into manufacturing and packaging processes will not only address environmental concerns but also resonate with increasingly value-driven procurement practices. Taken together, these recommendations form a cohesive blueprint for sustaining growth and maintaining competitive differentiation within the respiratory diagnostics landscape.

Elucidating a Rigorous Multi-Phased Research Framework Integrating Primary Validation and Secondary Analysis for Robust Respiratory Diagnostics Intelligence

This research employs a meticulous multi-phased approach to ensure the highest level of accuracy and reliability. Primary data collection involved comprehensive interviews with key opinion leaders, including pulmonologists, laboratory directors, and regulatory specialists, to capture firsthand insights on emerging trends, clinical workflows, and procurement drivers. These qualitative findings were supplemented by a detailed review of public filings, technical whitepapers, and regulatory databases, providing a robust secondary data foundation.

Quantitative analysis was conducted through data triangulation methodologies, cross-referencing supply chain metrics, healthcare expenditure reports, and product launch timelines. The resulting data sets underwent rigorous validation, employing statistical techniques to identify outliers and verify consistency. Additionally, a proprietary assessment framework evaluated each technology's maturity, adoption potential, and competitive positioning. This layered research protocol ensures that conclusions are grounded in empirical evidence and reflect the latest evolutions shaping respiratory diagnostics.

Synthesizing Key Discoveries and Future Trajectories to Guide Strategic Progression in Respiratory Diagnostic Endeavors and Sector Perspectives

Drawing together the critical insights outlined throughout this summary, it becomes clear that respiratory diagnostics is entering an era defined by digital integration, strategic supply chain realignment, and collaborative innovation. The interplay between advanced imaging platforms and molecular assays is driving a more nuanced understanding of respiratory pathologies. Simultaneously, regulatory reforms and tariff policies underscore the importance of operational agility and proactive stakeholder engagement.

Looking ahead, organizations that embrace modular, data-driven solutions and cultivate diverse partnerships will be best positioned to navigate market complexities. By applying the strategic imperatives detailed here, decision-makers can capitalize on emerging opportunities, mitigate potential risks, and deliver enhanced patient outcomes. Ultimately, this report offers a roadmap for achieving sustained growth and leadership in a dynamic respiratory diagnostics environment, supporting stakeholders in making informed, future-focused choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Respiratory Diagnostics Market, by Diagnostic Tests

  • 8.1. Blood Tests
    • 8.1.1. Arterial Blood Gases
    • 8.1.2. Complete Blood Count
  • 8.2. Imaging Tests
    • 8.2.1. Chest X-Rays
    • 8.2.2. CT Scans
    • 8.2.3. MRI Scans
  • 8.3. Lung Function Tests
    • 8.3.1. Diffusion Capacity Tests
    • 8.3.2. Lung Volume Tests
    • 8.3.3. Spirometry
  • 8.4. Molecular Tests
    • 8.4.1. Antigen Tests
    • 8.4.2. Biomarker Tests
    • 8.4.3. PCR Tests
  • 8.5. Pulse Oximetry
  • 8.6. Sputum Tests

9. Respiratory Diagnostics Market, by Patient Demographics

  • 9.1. Adult
  • 9.2. Geriatric
  • 9.3. Pediatric

10. Respiratory Diagnostics Market, by Offerings

  • 10.1. Equipment
    • 10.1.1. Body Plethysmographs
    • 10.1.2. Diagnostic Imaging Systems
    • 10.1.3. Gas Analysis Devices
    • 10.1.4. Spirometry Systems
  • 10.2. Services
  • 10.3. Software
    • 10.3.1. Data Analytics Software
    • 10.3.2. Imaging Analysis Software
    • 10.3.3. Pulmonary Function Testing (PFT) Software

11. Respiratory Diagnostics Market, by End Users

  • 11.1. Academic Institutions
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics
  • 11.4. Research Institutes

12. Respiratory Diagnostics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Respiratory Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Respiratory Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Respiratory Diagnostics Market

16. China Respiratory Diagnostics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Adaltis S.r.l.
  • 17.7. Altona Diagnostics GmbH
  • 17.8. Becton, Dickinson, and Company
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. bioMerieux S.A.
  • 17.11. Bioneer Corporation
  • 17.12. CerTest Biotec S.L.
  • 17.13. Daan Gene Co., Ltd.
  • 17.14. Diatech Pharmacogenetics srl
  • 17.15. Dragerwerk AG & Co. KGaA
  • 17.16. F. Hoffmann-La Roche Ltd.
  • 17.17. GE HealthCare Technologies, Inc.
  • 17.18. Hologic, Inc.
  • 17.19. Johnson & Johnson Services, Inc.
  • 17.20. Koninklijke Philips N.V.
  • 17.21. Masimo Corporation
  • 17.22. Medtronic PLC
  • 17.23. Merck KGaA
  • 17.24. ProAxsis by NetScientific PLC
  • 17.25. Quest Diagnostics Incorporated
  • 17.26. Quidel Corporation
  • 17.27. ResMed Corp.
  • 17.28. Sansure Biotech Inc.
  • 17.29. SDI Diagnostics, Inc.
  • 17.30. Seegene Inc.
  • 17.31. Siemens Healthineers AG
  • 17.32. Thermo Fisher Scientific Inc.
  • 17.33. Vitalograph Ltd.
  • 17.34. ZeptoMetrix LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 224. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 254. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 264. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)